Lichen planopilaris is associated with HLA DRB1*11 and DQB1*03 alleles

Acta Dermato-Venereologica

Volumn 95, Issue 2, 2015, Pages 177-180

  Pavlovsky, Lev ^a,b   Israeli, Moshe ^a   Sagy, Eti ^a   Berg, Amy L ^b   David, Michael ^a,b   Shemer, Avner ^b,c   Klein, Tirza ^a,b   Hodak, Emmilia ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

Author keywords

Alopecia; Ethnicity; Lichen planopilaris; Major histocompatibility complex

Indexed keywords

HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; HLA DQ ANTIGEN; HLA-DQB1 ANTIGEN; HLA-DRB1*11 ANTIGEN;

ADULT; AGED; ALLELISM; ARTICLE; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; HUMAN; IMMUNOGENETICS; LICHEN (DISEASE); LICHEN PLANOPILARIS; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; CASE CONTROL STUDY; EPIDEMIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; ISRAEL; JEW; LICHEN PLANUS; MIDDLE AGED; PHENOTYPE; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HLA-DQ BETA-CHAINS; HLA-DRB1 CHAINS; HUMANS; ISRAEL; JEWS; LICHEN PLANUS; MALE; MIDDLE AGED; PHENOTYPE; RISK FACTORS;

EID: 84928266482     PISSN: 00015555     EISSN: 16512057     Source Type: Journal    
DOI: 10.2340/00015555-1884     Document Type: Article

References (39)

1. Assouly P, Reygagne P. Lichen planopilaris: update on diagnosis and treatment. Semin Cutan Med Surg 2009; 28: 3–10.
2. Mehregan DA, Van Hale HM, Muller SA. Lichen planopilaris: clinical and pathologic study of forty-five patients. J Am Acad Dermatol 1992; 27: 935–942.
3. Tandon YK, Somani N, Cevasco NC, Bergfeld WF. A histologic review of 27 patients with lichen planopilaris. J Am Acad Dermatol 2008; 59: 91–98.
4. Jiang H, Chess L. Regulation of immune responses by T cells. N Engl J Med 2006; 354: 1166–1176.
5. Carrozzo M, Elia A, Mereu V, Dametto E, Fasano M, Broccoletti R, et al. HLA-C/KIR genotypes in oral lichen planus patients infected or non-infected with hepatitis C virus. Oral Dis 2011; 17: 309–313.
6. Luis-Montoya P, Yamamoto-Furusho JK, Vega-Memije E, Rodríguez-Carreón A, Ruiz-Morales JA, Vargas-Alarcón G, et al. HLA-DRB1*0101 is associated with the genetic susceptibility to develop lichen planus in the Mexican Mestizo population. Arch Dermatol Res 2007; 299: 405–407.
7. Setterfield JF, Neill S, Shirlaw PJ, Theron J, Vaughan R, Escudier M, et al. The vulvovaginal gingival syndrome: a severe subgroup of lichen planus with characteristic clinical features and a novel association with the class II HLA DQB1*0201 allele. J Am Acad Dermatol 2006; 55: 98–113.
8. Carrozzo M, Brancatello F, Dametto E, Arduino P, Pentenero M, Rendine S, et al. Hepatitis C virus-associated oral lichen planus: is the geographical heterogeneity related to HLA-DR6? J Oral Pathol Med 2005; 34: 204–208.
9. Carrozzo M, Francia Di Celle P, Gandolfo S, Carbone M, Conrotto D, Fasano ME, et al. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 2001; 144: 803–808.
10. Sun A, Wu YC, Wang JT, Liu BY, Chiang CP. Association of HLA-te22 antigen with anti-nuclear antibodies in Chinese patients with erosive oral lichen planus. Proc Natl Sci Counc Repub China B 2000; 24: 63–69.
11. Ognjenović M, Karelović D, Cindro VV, Tadin I. Oral lichen planus and HLA. A. Coll Antropol 1998; 22 Suppl: 89–92.
12. Ognjenović M, Karelović D, Mikelić M, Tadin I, Vrebalov-Cindro V. Oral lichen planus and HLA. B. Coll Antropol 1998; 22 Suppl: 93–96.
13. Ognjenović M, Karelović D, Cekić-Arambasin A, Tadin I, Vrebalov-Cindro V. Oral lichen planus and HLA DR. Coll Antropol 1998; 22 Suppl: 97–101.
14. Gonzalez-Moles M, Ruiz-Avila I, Muwaquet-Rodriguez S, Fernandez-Martinez J, Bravo I, Esteban-Ortega F. HLA-DR and intercelular adhesion molecula-1 (ICAM-1) expression in oral lichen planus. Med Oral 1997; 2: 14–20.
15. La Nasa G, Cottoni F, Mulargia M, Carcassi C, Vacca A, Pizzati A, et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Br J Dermatol 1995; 132: 897–900.
16. Roitberg-Tambur A, Friedmann A, Korn S, Markitziu A, Pisanti S, Safirman C, et al. Serologic and molecular analysis of the HLA system in Israeli Jewish patients with oral erosive lichen planus. Tissue Antigens 1994; 43: 219–223.
17. White AG, Rostom AI. HLA antigens in Arabs with lichen planus. Clin Exp Dermatol 1994; 19: 236–237.
18. Porter K, Klouda P, Scully C, Bidwell J, Porter S. Class I and II HLA antigens in British patients with oral lichen planus. Oral Surg Oral Med Oral Pathol 1993; 75: 176–180.
19. Lin SC, Sun A. HLA-DR and DQ antigens in Chinese patients with oral lichen planus. J Oral Pathol Med 1990; 19: 298–300.
20. Valsecchi R, Bontempelli M, Rossi A, Bellavita P, Barcella A, Di Landro A, et al. HLA-DR and DQ antigens in lichen planus. Acta Derm Venereol 1988; 68: 77–80.
21. Powell FC, Rogers RS, Dickson ER, Moore SB. An association between HLA DRI and lichen planus. Br J Dermatol 1986; 114: 473–478.
22. Watanabe T, Ohishi M, Tanaka K, Sato H. Analysis of HLA antigens in Japanese with oral lichen planus. J Oral Pathol 1986; 15: 529–533.
23. Simon M, Djawari D, Schönberger A. HLA antigens associated with lichen planus. Clin Exp Dermatol 1984; 9: 435.
24. Veien NK, Risum G, Jørgensen HP, Svejgaard A. HLA antigens in patients with lichen planus. Acta Derm Venereol 1979; 59: 205–209.
25. Hodak E, Lapidoth M, Kohn K, David D, Brautbar B, Kfir K, et al. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients. Br J Dermatol 2001; 145: 974–980.
26. Rosner G, Rosner S, Orr-Urtreger A. Genetic testing in Israel: an overview. Annu Rev Genomics Hum Genet 2009; 10: 175–192.
27. Mobini N, Tam S, Kamino H. Possible role of the bulge region in the pathogenesis of inflammatory scarring alopecia: lichen planopilaris as the prototype. J Cutan Pathol 2005; 32: 675–679.
28. Ochoa BE, King LE, Price VH. Lichen planopilaris: annual incidence in four hair referral centers in the United States. J Am Acad Dermatol 2008; 58: 352–353.
29. Cevasco NC, Bergfeld WF, Remzi BK, de Knott HR. A case-series of 29 patients with lichen planopilaris: the Cleveland Clinic Foundation experience on evaluation, diagnosis, and treatment. J Am Acad Dermatol 2007; 57: 47–53.
30. Tan E, Martinka M, Ball N, Shapiro J. Primary cicatricial alopecias: clinicopathology of 112 cases. J Am Acad Dermatol 2004; 50: 25–32.
31. Hitchcock MG, Burchette JL, Olsen EA, Ratech H, Kamino H. Eccrine gland infiltration by mycosis fungoides. Am J Dermatopathol 1996; 18: 447–453.
32. Klitz W, Gragert L, Maiers M, Fernandez-Viña M, Ben-Naeh Y, Benedek G, et al. Genetic differentiation of Jewish populations. Tissue Antigens 2010; 76: 442–458.
33. Behar DM, Yunusbayev B, Metspalu M, Metspalu E, Rosset S, Parik J, et al. The genome-wide structure of the Jewish people. Nature 2010; 466: 238–242.
34. Shamis I, Gordon O, Albag Y, Goldsand G, Laron Z. Ethnic differences in the incidence of childhood IDDM in Israel (1965–1993). Marked increase since 1985, especially in Yemenite Jews. Diabetes Care 1997; 20: 504–508.
35. Mimouni D, Bar H, Gdalevich M, Katzenelson V, David M. Pemphigus – analysis of epidemiological factors in 155 patients. J Eur Acad Dermatol Venereol 2008; 22: 1232–1235.
36. Maiers M, Gragert L, Klitz W. High-resolution HLA alleles and haplotypes in the United States population. Hum Immunol 2007; 68: 779–788.
37. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest 2007; 117: 2019–2027.
38. Megiorni F, Pizzuti A, Mora B, Rizzuti A, Garelli V, Maxia C, et al. Genetic association of HLA-DQB1 and HLADRB1 polymorphisms with alopecia areata in the Italian population. Br J Dermatol 2011; 165: 823–827.
39. Karnik P, Tekeste Z, McCormick TS, Gilliam AC, Price VH, Cooper KD, et al. Hair follicle stem cell-specific PPARgamma deletion causes scarring alopecia. J Invest Dermatol 2009; 129: 1243–1257.